FDA panel to consider loosening regulations for some peptides
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
FDA panel to consider loosening regulations for some peptides
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.